Form 4: Co-Diagnostics, Inc. (CODX), Benson Reed L, transaction 05/19/2021

Summary

A Form 4 filed with the Securities and Exchange Commission by Reed L. Benson, General Counsel of Co-Diagnostics, Inc. (CODX), reporting transactions on 05/19/2021. The reporting person exercised stock options for 10,920 and 97,413 shares at an exercise price of $2.63 and for 1 share at $1.1, then sold those shares the same day: 10,920 at a weighted average price of $8.5377 and 97,413 at $8.5244, plus 1 share at $8.53. The footnotes state the larger sales were executed in multiple trades at prices ranging from $8.52 to $8.55 and from $8.47 to $8.64. After the exercises, 13,891 options at $1.1 expiring 09/02/2029 remained. The form is signed /s/ Reed L. Benson and dated 05/21/2021.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Cite this document

“Form 4: Co-Diagnostics, Inc. (CODX), Benson Reed L, transaction 05/19/2021.” Original at www.sec.gov. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/sec-codx-4-filed2021-05-21-0001562180-21-003687-75ec589c6f/, SHA-256 45b4aeda310f83a1804717167b27cc10861f205843ab167e665675c218e48d08.

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * BENSON REED L (Last) (First) (Middle) 2401 S. FOOTHILL DRIVE SUITE D (Street) SALT LAKE CITY UT 84109 (City) (State) (Zip) | BENSON REED L | (Last) | (First) | (Middle) | 2401 S. FOOTHILL DRIVE SUITE D | SALT LAKE CITY | UT | 84109 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Co-Diagnostics, Inc. [ CODX ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) General Counsel | Director | 10% Owner | X | Officer (give title below) | Other (specify below) | General Counsel
3. Date of Earliest Transaction
 (Month/Day/Year) 05/19/2021
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 05/19/2021 | M | 1 | A | $ 1.1 | 1 | D
Common Stock | 05/19/2021 | M | 10,920 | A | $ 2.63 | 10,921 | D
Common Stock | 05/19/2021 | M | 97,413 | A | $ 2.63 | 108,334 | D
Common Stock | 05/19/2021 | S | 10,920 | D | $ 8.5377 (1) | 97,414 | D
Common Stock | 05/19/2021 | S | 97,413 | D | $ 8.5244 (2) | 1 | D
Common Stock | 05/19/2021 | S | 1 | D | $ 8.53 | 0.00 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Stock Option (Right to Buy) | $ 2.63 | 05/19/2021 | M | 97,413 | (3) | 09/20/2028 | Common Stock | 97,413 | $ 0.00 | 0.00 | D
Stock Option (Right to Buy) | $ 2.63 | 05/19/2021 | M | 10,920 | (3) | 09/20/2028 | Common Stock | 10,920 | $ 0.00 | 0.00 | D
Stock Option (Right to Buy) | $ 1.1 | 05/19/2021 | M | 1 | (4) | 09/02/2029 | Common Stock | 1 | $ 0.00 | 13,891 | D
Explanation of Responses:
1. This transaction was executed in multiple trades at prices ranging from $8.52 USD to $8.55 USD; the price reported above reflects the weighted average sale price.
2. This transaction was executed in multiple trades at prices ranging from $8.47 USD to $8.64 USD; the price reported above reflects the weighted average sale price.
3. 1/3 on day of grant; 1/3 after year 1, 1/3 after year 2 beginning on 21-Sep-2018
4. 1/3 on day of grant; 1/3 after year 1, 1/3 after year 2 beginning on 03-Sep-2019
Remarks:
/s/ Reed L. Benson | 05/21/2021
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File: SEC_CODX_4_filed2021-05-21_0001562180-21-003687.xml
Size: 22,004 bytes
SHA-256: 45b4aeda310f83a1804717167b27cc10861f205843ab167e665675c218e48d08
Our copy: SEC_CODX_4_filed2021-05-21_0001562180-21-003687.xml
Original: www.sec.gov